This is a preview of subscription content, log in via an institution to check access.
Change history
23 August 2017
In the August 2017 issue, the story “Breaking through: How researchers are gaining entry into barricaded bacteria” (Nat. Med. 23, 907–910, 2017) misstated that the pharmaceutical company Achaogen would be filing a New Drug Application with the FDA in 2018. The company will be filing an Investigational New Drug application. The article was also unclear in wording the progress of siderophore-conjugated antibiotics. Such antibiotics have made it to clinical trials, but none so far have made it to market. The errors have been corrected in the HTML and PDF versions of the article as of 23 August 2017.
Author information
Author notes
Shraddha Chakradhar is Nature Medicine's associate news editor in Boston.
- Shraddha Chakradhar
Rights and permissions
About this article
Cite this article
Chakradhar, S. Breaking through: How researchers are gaining entry into barricaded bacteria. Nat Med 23, 907–910 (2017). https://doi.org/10.1038/nm0817-907
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0817-907
- Springer Nature America, Inc.
This article is cited by
-
In vivo bioluminescence imaging of natural bacteria within deep tissues via ATP-binding cassette sugar transporter
Nature Communications (2023)
-
Correction
Nature Medicine (2017)